Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...
Large-cap public M&A is a hard business to break into, but Paul Hastings feels its build, along with the arrival of Schiele, ...
AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, which spun out of Pfizer ...
Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy ...
After hours: March 11 at 4:20:00 PM EDT Loading Chart for SLNO ...
After hours: March 13 at 4:41:26 PM EDT Loading Chart for FOLD ...